The effects of desflurane and sevoflurane on hepatic and renal functions after right hepatectomy in living donors

Transplant International

Volumn 23, Issue 7, 2010, Pages 736-744

  Ko, Justin S ^a   Gwak, Mi S ^a   Choi, Soo J ^a   Yang, Mikyung ^a   Kim, Myung J ^a   Lee, Jin Y ^a   Kim, Gaab S ^a   Kwon, Choon H D ^a   Joh, Jae W ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Desflurane; Liver function tests; Living donor right hepatectomy; Renal function tests; Sevoflurane

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CREATININE; DESFLURANE; MORPHINE SULFATE; REMIFENTANIL; SEVOFLURANE; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; ISOFLURANE; PIPERIDINE DERIVATIVE;

ADULT; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION; HEMODYNAMIC PARAMETERS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; LIVER FAILURE; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER RESECTION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; TIME SERIES ANALYSIS; ANALOGS AND DERIVATIVES; ANESTHETIC RECOVERY; BLOOD; DRUG EFFECTS; GLOMERULUS FILTRATION RATE; LIVER; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALANINE TRANSAMINASE; ANESTHESIA RECOVERY PERIOD; ANESTHETICS, INHALATION; ASPARTATE AMINOTRANSFERASES; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HEPATECTOMY; HUMANS; ISOFLURANE; KIDNEY FUNCTION TESTS; LIVER; LIVING DONORS; MALE; METHYL ETHERS; PIPERIDINES;

EID: 77953183495     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2009.01050.x     Document Type: Article

References (39)

1. de Villa VH, Lo CM, Chen CL. Ethics and rationale of living-donor liver transplantation in Asia. Transplantation 2003 75 : S2.
2. Pomfret EA. Early and late complications in the right-lobe adult living donor. Liver Transpl 2003 9 : S45.
3. Trotter JF, Adam R, Lo CM, Kenison J. Documented deaths of hepatic lobe donors for living donor liver transplantation. Liver Transpl 2006 12 : 1485.
4. Akabayashi A, Slingsby BT, Fujita M. The first donor death after living-related liver transplantation in Japan. Transplantation 2004 77 : 634.
5. Schumann R, Zabala L, Angelis M, Bonney I, Tighiouart H, Carr DB. Altered hematologic profiles following donor right hepatectomy and implications for perioperative analgesic management. Liver Transpl 2004 10 : 363.
6. Ko JS, Gwak MS, Choi SJ, et al. The effects of desflurane and propofol-remifentanil on postoperative hepatic and renal functions after right hepatectomy in liver donors. Liver Transpl 2008 14 : 1150.
7. Beck-Schimmer B, Breitenstein S, Urech S, et al. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 2008 248 : 909.
8. Chhibber A, Dziak J, Kolano J, Norton JR, Lustik S. Anesthesia care for adult live donor hepatectomy: our experiences with 100 cases. Liver Transpl 2007 13 : 537.
9. Siniscalchi A, Begliomini B, De Pietri L, et al. Increased prothrombin time and platelet counts in living donor right hepatectomy: implications for epidural anesthesia. Liver Transpl 2004 10 : 1144.
10. Ko JS, Choi SJ, Gwak MS, et al. Intrathecal morphine combined with intravenous patient-controlled analgesia is an effective and safe method for immediate postoperative pain control in live liver donors. Liver Transpl 2009 15 : 381.
11. Punjasawadwong Y, Boonjeungmonkol N, Phongchiewboon A. Bispectral index for improving anaesthetic delivery and postoperative recovery. Cochrane Database Syst Rev 2007 17 : CD003843.
12. Choi SJ, Gwak MS, Ko JS, et al. Can peripheral venous pressure be an alternative to central venous pressure during right hepatectomy in living donors? Liver Transpl 2007 13 : 1414.
13. Chung F. Discharge criteria - a new trend. Can J Anaesth 1995 42 : 1056.
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 1999 130 : 461.
15. Pollard RJ, Coyle JP, Gilbert RL, Beck JE. Intraoperative awareness in a regional medical system: a review of 3 years' data. Anesthesiology 2007 106 : 269.
16. Bito H, Ikeda K. Renal and hepatic function in surgical patients after low-flow sevoflurane or isoflurane anesthesia. Anesth Analg 1996 82 : 173.
17. Obata R, Bito H, Ohmura M, et al. The effects of prolonged low-flow sevoflurane anesthesia on renal and hepatic function. Anesth Analg 2000 91 : 1262.
18. Ebert TJ, Frink EJ Jr., Kharasch ED. Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers. Anesthesiology 1998 88 : 601.
19. Ebert TJ, Messana LD, Uhrich TD, Staacke TS. Absence of renal and hepatic toxicity after four hours of 1.25 minimum alveolar anesthetic concentration sevoflurane anesthesia in volunteers. Anesth Analg 1998 86 : 662.
20. Eger EI II., Gong D, Koblin DD, et al. Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 1997 85 : 1154.
21. Eger EI II., Koblin DD, Bowland T, et al. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 1997 84 : 160.
22. Gelman S. General anesthesia and hepatic circulation. Can J Physiol Pharmacol 1987 65 : 1762.
23. Frink EJ Jr., Morgan SE, Coetzee A, Conzen PF, Brown BR Jr. The effects of sevoflurane, halothane, enflurane, and isoflurane on hepatic blood flow and oxygenation in chronically instrumented greyhound dogs. Anesthesiology 1992 76 : 85.
24. Hartman JC, Pagel PS, Proctor LT, Kampine JP, Schmeling WT, Warltier DC. Influence of desflurane, isoflurane and halothane on regional tissue perfusion in dogs. Can J Anaesth 1992 39 : 877.
25. Mazze RI, Calverley RK, Smith NT. Inorganic fluoride nephrotoxicity: prolonged enflurane and halothane anesthesia in volunteers. Anesthesiology 1977 46 : 265.
26. Jones RM, Koblin DD, Cashman JN, Eger EI II., Johnson BH, Damask MC. Biotransformation and hepato-renal function in volunteers after exposure to desflurane (I-653). Br J Anaesth 1990 64 : 482.
27. Kharasch ED, Armstrong AS, Gunn K, Artru A, Cox K, Karol MD. Clinical sevoflurane metabolism and disposition. II. The role of cytochrome P450 2E1 in fluoride and hexafluoroisopropanol formation. Anesthesiology 1995 82 : 1379.
28. Sutton TS, Koblin DD, Gruenke LD, et al. Fluoride metabolites after prolonged exposure of volunteers and patients to desflurane. Anesth Analg 1991 73 : 180.
29. Al-Ghanem SM, Massad IM, Al-Barazangi B, Al-Mustafa M, Daoud FS, Abu-Ali H. Effects of sevoflurane on postoperative liver functions in morbidly obese as compared to the non-obese patients. Middle East J Anesthesiol 2009 20 : 207.
30. Lehmann A, Neher M, Kiessling AH, Isgro F, Koloska A, Boldt J. Case report: fatal hepatic failure after aortic valve replacement and sevoflurane exposure. Can J Anaesth 2007 54 : 917.
31. Turillazzi E, D'Errico S, Neri M, Riezzo I, Fineschi V. A fatal case of fulminant hepatic necrosis following sevoflurane anesthesia. Toxicol Pathol 2007 35 : 840.
32. Reichle FM, Conzen PF. Halogenated inhalational anaesthetics. Best Pract Res Clin Anaesthesiol 2003 17 : 29.
33. Holaday DA, Smith FR. Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers. Anesthesiology 1981 54 : 100.
34. Keller KA, Callan C, Prokocimer P, et al. Inhalation toxicity study of a haloalkene degradant of sevoflurane, Compound A (PIFE), in Sprague-Dawley rats. Anesthesiology 1995 83 : 1220.
35. Yasuda N, Lockhart SH, Eger EI 2nd., et al. Kinetics of desflurane, isoflurane, and halothane in humans. Anesthesiology 1991 74 : 489.
36. Yasuda N, Lockhart SH, Eger EI 2nd., et al. Comparison of kinetics of sevoflurane and isoflurane in humans. Anesth Analg 1991 72 : 316.
37. Eger EI 3rd. Stability of I-653 in soda lime. Anesth Analg 1987 66 : 983.
38. Cousins MJ, Mazze RI. Methoxyflurane nephrotoxicity. A study of dose response in man. JAMA 1973 225 : 1611.
39. Bito H, Ikeda K. Plasma inorganic fluoride and intracircuit degradation product concentrations in long-duration, low-flow sevoflurane anesthesia. Anesth Analg 1994 79 : 946.